Theodore F. Logan

机构：Indiana University Health, Indiana Cancer Consortium, ARTS Group (China), Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University – Purdue University Indianapolis · ORCID：0000-0002-9245-0820

发表论文 180 篇 · 总被引 12142 次 · h-index 44

代表论文

• NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024 (2024 · Journal of the National Comprehensive Cancer Network · 被引 149)
• Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 96)
• A Phase I/ IB , Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma (2025 · Cancer Medicine · 被引 6)
• Abstract 3275: Combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progression on a prior PD-1 inhibitor: SWOG S1607 (2023 · Cancer Research · 被引 5)
• NyokAssist™ Percutaneous Ventricular Assist Device with Foldable Catheter Pump: Early Report from Clinical Trial (2025 · The Journal of Heart and Lung Transplantation · 被引 2)
• A phase I/II study to evaluate the safety, pharmacodynamics, and efficacy of entinostat in combination with atezolizumab and bevacizumab in patients with renal cell carcinoma. (2023 · Journal of Clinical Oncology · 被引 2)